Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.

Authors: Murphy, DM  Bejar, R  Stevenson, K  Neuberg, D  Shi, Y  Cubrich, C  Richardson, K  Eastlake, P  Garcia-Manero, G  Kantarjian, H  Ebert, BL  Mike Makrigiorgos, G 
Citation: Murphy DM, etal., Leukemia. 2013 Oct;27(10):2077-81. doi: 10.1038/leu.2013.160. Epub 2013 May 27.
Pubmed: (View Article at PubMed) PMID:23708912
DOI: Full-text: DOI:10.1038/leu.2013.160



Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 11535060
Created: 2016-09-20
Species: All species
Last Modified: 2016-09-20
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.